ADHD, Perimenopause and Noradrenaline: Why Brain Fog Happens
If you've been mid-sentence and watched a word just disappear before you could say it, or stood in a room with no idea why you walked in, you already know perimenopause brain fog isn't the same as being a bit tired. It's different than that, and much harder to think your way out of. By the end of this, you'll understand exactly why that happens, what a brain chemical called noradrenaline has to do with it, how closely it's tied to your hormones, and why so many women fear they're developing early dementia when what's actually going on is hormonal.
What noradrenaline actually is
Noradrenaline, also called norepinephrine, is one of the brain's main alertness chemicals. Think of it as a bit like a spotlight operator backstage, deciding what gets lit up and brought into focus, and what stays in the dark as background noise. When it's working well, you can sit in a room with a ticking clock, a phone buzzing, and a task in front of you, and your brain lets the task win without a fight.
Noradrenaline works closely with dopamine, another brain chemical linked with ADHD. If dopamine is what gets you started and motivated, noradrenaline is what helps you stay locked onto the thing you started, holding it in mind long enough to actually finish it. Noradrenaline is also part of the body's stress response, working alongside cortisol, which is one reason stress can affect us differently at this stage of life, more on that shortly.
Why this matters for ADHD
In an ADHD brain, this spotlight system does not run as smoothly. That is a big part of why focus and short term memory can feel like such hard work, it is not that people with ADHD are not paying attention, it is that the system deciding what deserves attention is working differently.
This is also why some ADHD medications, like atomoxetine, work directly on noradrenaline rather than only on dopamine. In adults with ADHD, atomoxetine has been shown to increase activity in the prefrontal cortex, the brain region responsible for planning and focus, particularly in people who respond well to the medication (Sugimoto et al., 2021).
Why oestrogen and noradrenaline are so closely linked
Oestrogen is not only involved in reproduction, it also helps noradrenaline do its job properly in the exact part of the brain responsible for memory and attention. So when oestrogen levels start fluctuating and lowering during perimenopause, it is not only mood and motivation affected, the system that keeps your attention and memory running smoothly is directly affected too (Kooij et al., 2025).
Oestrogen actually supports several brain systems at once, not just this one, including how the brain uses energy and how brain cells communicate with each other (Brinton et al., 2015). Noradrenaline is just one part of a much bigger support system that loses some of its effectiveness at the same time.
What happens when oestrogen drops
As oestrogen declines in perimenopause, the noradrenaline system becomes less efficient. Working memory, your brain's ability to hold information for just long enough to use it, gets harder and the brain becomes easier to overwhelm.
This is why brain fog at this stage feels different from ordinary tiredness, and women are right to notice that difference. Losing a word mid sentence. Walking into a room and forgetting why. Rereading the same paragraph three times. None of that is a sign of not trying hard enough. It is a sign of a system that has lost some of the support it relied on.
Why this often gets mistaken for early dementia
Because the memory changes can feel so noticeable, it is common for women to worry they are developing early dementia, especially if a parent or relative has been affected by it. That fear deserves to be taken seriously, not brushed off, and it also deserves accurate information. The cognitive changes most women describe in perimenopause line up with a temporary drop in noradrenaline and oestrogen support, not with degeneration of the brain, and they tend to ease once hormone levels settle or are properly supported.
That said, any sudden or severe change in memory or thinking should always be raised with a doctor, both to rule out other causes and to get the right support sooner.
What actually helps
HRT that restores oestrogen can help support the noradrenaline system directly, alongside whatever else it improves (Sharma et al., 2023). ADHD medication may also need reviewing during perimenopause, not because it has stopped working, but because the hormonal environment it works within has changed.
Reducing how many things compete for your attention at once tends to help far more than pushing harder through sheer effort. Writing things down the moment they occur to you, rather than trusting you will remember later, stops being a nice habit and becomes genuinely necessary at this stage, because working memory cannot be relied on the way it once was. Reducing background stress where you realistically can helps too, since a noradrenaline system already running on less support has far less spare capacity for anything extra.
Oestrogen helps noradrenaline keep your attention and memory in order. When that support changes, that is when the struggle shows up, in things like finding the right word or holding onto a thought long enough to finish it. This is a genuine change in your brain chemistry, and it deserves to be taken seriously and properly supported.
References
Brinton, R.D., Yao, J., Yin, F., Mack, W.J. and Cadenas, E. (2015) 'Perimenopause as a neurological transition state', Nature Reviews Endocrinology, 11(7), pp. 393-405. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9934205/
Kooij, J.J.S. et al. (2025) 'Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition, and disease', Frontiers in Global Women's Health, 6, article 1613628. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12277363/
Sharma, A., Goel, A., Dhayalan, J., Kamali Zare, V., Hanson, L. and Yalamanchi, S. (2023) 'The effect of hormone replacement therapy on cognition and mood', Clinical Endocrinology, 98(3), pp. 285-295. Available at: https://onlinelibrary.wiley.com/doi/10.1111/cen.14856
Sugimoto, A., Suzuki, Y., Yoshinaga, K., Orime, N., Hayashi, T., Egawa, J., Ono, S., Sugai, T. and Someya, T. (2021) 'Influence of atomoxetine on relationship between ADHD symptoms and prefrontal cortex activity during task execution in adult patients', Frontiers in Human Neuroscience, 15, article 755025. Available at: https://doi.org/10.3389/fnhum.2021.755025
